Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study

By Jerkeman M.  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 414-419

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma

By Alacacioglu Inci   Ozcan Mehmet Ali   Ozkal Sermin   Piskin Ozden   Turgut Nurhilal   Demirkan Fatih   Ozsan Guner Hayri   Kargi Aydanur   Undar Bulent  

Hematology, Vol. 14, Iss. 2, 2009-04 ,pp. : 84-89

Maney Publishing

Access to resources Recommend Favorite

Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy

By Song Moo-Kon   Chung Joo-Seop   Sung-Yong Oh   Lee Gyeong-Won   Kim Seung-Geun   Seol Young-Mi   Shin Ho-Jin   Choi Young-Jin   Cho Goon-Jae   Shin Dong-Hoon   Yun Eun-Young  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 985-991

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

By Li J.   Wang L.   Shen Y.   Xia Z.   Chen Y.   Chen Q.   Chen Y.   Zeng X.   You J.   Qian Y.   Shen Z.  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 639-645

Springer Publishing Company

Access to resources Recommend Favorite

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

By Bosly A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite